CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Currently, she is a postdoctoral researcher at the Department of Parasitology at the Institute of Biomedical Sciences, University of São Paulo (ICB-USP); working at the Laboratory of Biochemistry of Tryps (LaBTryps), specifically in the following subjects: Proline metabolism; Structural analyzes of proline pathway intermediates; Development of knockout strains by CRISPR/Cas9; Identification of potential inhibitors through virtual screening. She holds a PhD in Biotechnology from the Interunit Postgraduate Program in Biotechnology at ICB-USP. She holds a Master in Science from the Graduate Program in Nursing and Health at Guarulhos University (UNG). Graduated in Biomedicine from UNG. She carried out scientific initiation at the Research Center on Neglected Diseases (NPDN) in the Institutional Program for Scientific Initiation of UNG-Round II-2016, in the voluntary modality. During the period of scientific initiation, master's and doctorate she acted, specifically, in the following subjects: Schistosoma mansoni; Drug discovery; Pre-clinical trials; Pharmacokinetic studies. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chagas disease is a protozoan disease caused by Trypanosoma cruzi, which affects 6 to 7 million people worldwide. Currently, the only two drugs available for the treatment of the disease are nifurtimox and benznidazole, which have limitations regarding efficacy and tolerance. Therefore, the search for new treatments and therapeutic targets is necessary; however, the complexity of the T. c…
Helminth diseases affect more than 1 billion people worldwide and are considered a major public health problem. Considered as neglected diseases, these diseases not only prevail in conditions of poverty, but also represent an obstacle to the development of countries and are crucial in maintaining the framework of inequality. since new drug design and development is a lengthy and costly pr…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 2 / 2 | All Scholarships |
| Associated processes | |